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Abstract
Biofabrication of living structures with desired topology and functionality requires the
interdisciplinary effort of practitioners of the physical, life and engineering sciences. Such
efforts are being undertaken in many laboratories around the world. Numerous approaches are
pursued, such as those based on the use of natural or artificial scaffolds, decellularized
cadaveric extracellular matrices and, most lately, bioprinting. To be successful in this
endeavor, it is crucial to provide in vitro micro-environmental clues for the cells resembling
those in the organism. Therefore, scaffolds, populated with differentiated cells or stem cells,
of increasing complexity and sophistication are being fabricated. However, no matter how
sophisticated scaffolds are, they can cause problems stemming from their degradation, eliciting
immunogenic reactions and other a priori unforeseen complications. It is also being realized
that ultimately the best approach might be to rely on the self-assembly and self-organizing
properties of cells and tissues and the innate regenerative capability of the organism itself, not
just simply prepare tissue and organ structures in vitro followed by their implantation. Here
we briefly review the different strategies for the fabrication of three-dimensional biological
structures, in particular bioprinting. We detail a fully biological, scaffoldless, print-based
engineering approach that uses self-assembling multicellular units as bio-ink particles and
employs early developmental morphogenetic principles, such as cell sorting and tissue fusion.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Self-assembly is the autonomous organization of components,
from an initial state into a final pattern or structure
without external intervention [1–4]. Living organisms, in
particular the developing embryo, are quintessential self-
organizing systems. Histogenesis and organogenesis are
examples of self-assembly processes, in which, through cell–
6 Author to whom any correspondence should be addressed.
cell and cell–extracellular matrix (ECM) interactions, the
developing organism and its parts gradually acquire their final
shape. Ultimately, the success of engineering and fabricating
functional living structures will depend on understanding the
principles of cellular self-assembly and our ability to employ
them. This fact is being gradually recognized across the
tissue-engineering community, as except for a few successes
[5–7] the field is yet to present viable solutions to the growing
demand for novel regenerative technologies. Thus, future
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biofabrication approaches (including but not restricted to
the field of tissue engineering) aimed at re-establishing the
functionality of damaged tissues and organs will need to
focus on mobilizing developmental morphogenetic processes
coupled with requirements of adult biology, in short, the
body’s innate regenerative capability [8–10]. We will need
to understand questions such as why the salamander can re-
grow its limb but we cannot [11], or why the liver is the
only internal human organ capable of regeneration [12]. This
is important because though there is always a hope that
in vitro tissue-engineering efforts will eventually lead to
the long awaited breakthrough, it is also possible that the
multileveled and evolutionary established nature of cells and
organisms will continue to defeat this hope.
In this review we overview recent progress in fabricating
living structures of definite shape and functionality by
implementing developmental principles and processes, and
describe a rapid prototyping technology that is based on the
bio-printing of self-assembling multicellular building blocks.
2. Fundamentals of tissue engineering
Tissue engineering has emerged as an interdisciplinary field
that applies the principles of engineering and life sciences
toward the development of tissue substitutes [13, 14]. The
fundamental goal of tissue engineering is to regenerate or
replace defective, diseased or missing tissues and organs.
Examples of engineered grafts that are currently under pre-
clinical studies include engineered skin, cartilage, bone, blood
vessels, skeletal muscle, bladder, trachea and myocardium
[9, 15–19]. Three ‘classical’ tissue-engineering approaches
include [20] (i) use of an instructive environment (e.g.
bioactive material) to recruit and guide host cells to regenerate
a tissue, (ii) delivery of repair cells and/or bioactive factors into
the damaged area and (iii) cultivation of cells on a biomaterial
scaffold in a culture system (bioreactor), under conditions
designed to engineer a functional tissue for implantation. In
all cases ((i) and (ii) in vivo, (iii) in vitro), the engineered
environments are designed to direct the cells—added from
exogenous sources or mobilized from the host—to regenerate
a specific tissue structure and function [9, 21–23]. When a
tissue is engineered in vitro, cells (the actual ‘tissue engineers’)
are placed into a biomaterial scaffold (providing the structural
and logistic template for tissue formation) and cultured in
a bioreactor (providing microenvironmental control and the
necessary molecular and physical regulatory signals). Once
a desired developmental stage is achieved (in most cases
measured by critical functional properties), the tissue construct
is implanted into the host, where further maturation and
integration are anticipated.
At this time, tissue engineering opens several exciting
possibilities: (i) to create functional grafts suitable for
implantation and repair of failing tissues, (ii) to study stem
cell behavior and developmental processes in the context
of controllable three-dimensional (3D) models of engineered
tissues and (iii) to utilize engineered tissues as models for
studies of physiology and disease [22–27].
Figure 1. Biomimetic paradigm. In vivo, the progression of tissue
development and remodeling depends on the interaction of time and
space gradients of multiple factors that are not entirely known. The
‘biomimetic’ approach to tissue engineering aims to utilize these
same factors through the design of biomaterial scaffolds (providing
structural, mechanical and logistic templates for cell attachment and
tissue formation) and bioreactors (providing environmental control,
exchange of nutrients and metabolites, and the molecular and
physical regulatory signals). This way, the biological requirements
inspire the design of tissue-engineering systems, whereas tissue
engineering provides controllable models of high fidelity for
regenerative biology studies. (Reproduced from [2] with permission
of Elsevier.)
In what follows, we briefly review some fundamentals
of classical tissue engineering and present examples of self-
assembly-based approaches.
2.1. Biomimetic approach to tissue engineering
In living organisms, tissue development is orchestrated
by numerous regulatory factors, dynamically interacting at
multiple levels, in space and time. Recent developments in
the field of tissue engineering are aimed at designing a new
generation of tissue-engineering systems with an in vivo like,
but fully controllable cell environment. Such a ‘biomimetic’
environment, as a result of biology and engineering interacting
at multiple levels [23, 26], should be suitable to direct the cells
to differentiate at the right time, in the right place and into
the right phenotype and eventually to assemble functional
tissues by using biologically derived design requirements
(figure 1). Thus, these environments must be able to
provide the cells with the same regulatory factors—molecular,
structural, and physical—that govern the in vivo cellular
processes [21, 24, 27], and thereby unlock their full potential
for tissue development and regeneration. Progress in the
environmental control of tissue growth and maturation in
bioreactors, directing cell fate using soluble clues (e.g.
morphogens), mechanical or electrical stimulation, are
increasingly orienting the field towards biologically inspired
designs with a real-time insight [9, 27].
2.2. Cell sources
The choice of repair cells is central to any of the many
different modalities of tissue engineering—injection of repair
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cells (with or without biomaterial), implantation of a fully
formed cell-based graft or mobilization of the host cells into
the site of injury [20, 23, 26, 28]. One obvious requirement
is that of immune tolerance of the repair cells. Utilization of
autologous adult stem cells (i.e. cells obtained from the patient)
has the advantage of being patient-specific and alleviating
immune rejection or transmission of disease. While adult
stem cells were first isolated from the bone marrow, recent
literature supports their presence in a variety of extramedullary
organs including adipose tissue, dental pulp, circulating blood,
amniotic fluid and joint synovium [29–33].
In general, adult human mesenchymal stem cells have
documented capacity to form a number of tissues (including
cartilage, bone, fat and blood vessels), but not necessarily
cardiac muscle, nerves, hepatocytes or Langerhans islets.
Embryonic-like stem cells, including the newly derived
induced pluripotent cells (iPS) [34, 35], have essentially
unlimited potential for expansion in vitro and differentiation
in multiple cell lineages. Recent exciting developments in
iPS cells from various human tissues opens the possibility
of creating autologous embryonic-like cells for cardiac
regeneration, with the caveat that the derivation of iPS
cells involves, at least at this time, genetic transformation.
It is expected, however, that the use of small molecules
will gradually and completely replace gene transfer in the
derivation protocols of patient-specific adult human cells. We
propose that the ‘conditioning’ of stem cells—both adult and
embryonic-like—by biophysical stimulation in 3D culture
settings may result in the stabilization and maturation of
differentiated cell phenotypes.
Several promising paths toward deriving the ‘right’ cells
for the repair of a range of human tissues and the right
technology to utilize their potential need to be pursued until
one or more of these options is translated into clinical practice.
2.3. Tissue-engineering scaffolds
Tissue replacements are developed by culturing cells on
three-dimensional scaffolds to develop functionality and then
implanted in vivo. Depending on what tissue is to be
replaced, the properties of scaffolds will vary along several
parameters, including biological substances used, porosity,
elasticity, stiffness and specific anatomical shapes. To make
a scaffold, biomaterials are processed into 3D architectures
suitable for cell seeding and cultivation.
The choice of biomaterial is generally guided by the
need to restore tissue-specific structure and cell signaling,
and to match the necessary physical behavior (such as load-
bearing or signal propagation). Scaffolds also need to
serve as ‘logistic templates’ by providing the cells with
specific topological features (from nano to micro and macro
scale), mechanical environment (that cells can sense at
multiple levels), surface ligands and the ability to release
cytokines. Some of the novel scaffold designs enable an
active and dynamic interplay with the cells [21]. As the
cells deposit their own extracellular matrix, the scaffold-
biomaterial is expected to fully degrade and a tissue-like
structure to form and progressively integrate within the
surrounding host tissue upon implantation. This approach
has been implemented in the reconstruction of various tissues,
including skin, bone, cartilage, meniscus and bladder, and
has, in some cases, been further translated to clinical practice
[5, 36–39].
Scaffold-based tissue engineering faces some challenges
[40, 41], including (i) immunogenicity, (ii) acute and long-
term inflammatory response resulting from the host response
to the scaffold and its biodegradation products, (iii) mechanical
mismatch with the surrounding tissue, (iv) difficulties in
incorporating high numbers of cells uniformly distributed
within the scaffold and (v) limitations in introducing multiple
cell types with positional specificity. These difficulties,
along with the increased understanding of developmental
and morphogenetic processes, have led many groups toward
the development of ‘self-assembly’ approaches in which
individual cells organize into multicellular subunits (e.g.
spheroids, sheets or cylinders) [42–45]. The individual
subunits further arrange themselves into larger tissue structures
with little intervention and in most cases without the use of
exogenous scaffolds [46, 47].
2.4. Scaffold-free tissue engineering
Functional small-caliber arteries were engineered by cell
cultivation on biodegradable fibrous polyglycolic acid (PGA)
scaffolds in a bioreactor with dynamic pulsatile flow
[48]. Collagen deposition and alignment during construct
maturation is crucial for achieving adequate mechanical
strength (e.g. burst pressure) needed for implantation.
Maturation of vascular constructs under cyclic radial strain
allowed for circumferential assembly and alignment of
collagen in a helicoidal pattern similar to native blood vessels
[49]. However, the use of biodegradable scaffold led to the
residual presence of polymer fragments disrupting the normal
organization of the vascular wall [50]. For such a mechanically
demanding application, balancing the degradation rate of the
scaffold material with tissue remodeling in the patient remains
a challenge.
In parallel, self-assembly (in particular, scaffold-free)
approaches demonstrate that fully biological tissues can
be engineered with specific compositions and shapes, by
exploiting cell–cell adhesion and the ability of cultured cells
to grow their own ECM, and thereby help reduce and mediate
inflammatory responses. One of the impressive examples of
self-assembly methods is the sheet-based tissue-engineering
technology developed by L’Heureux and colleagues [43].
Using this approach, sheets of human smooth muscle cells
(SMC) and fibroblasts were grown on culture plates in the
presence of ascorbic acid to enhance collagen production,
detached and wrapped around a porous, tubular mandrel to
form the equivalents of media and adventitia of blood vessels.
After several weeks of maturation in a bioreactor, lumens of
the constructs were seeded with endothelial cells (EC). The
resulting structures displayed strong mechanical properties,
well-defined multilayer organization and an abundant,
organized ECM. Autologous small-diameter vascular grafts
engineered using this method are currently in clinical trials for
hemodialysis access [44].
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Okano and colleagues have developed a similar
‘self-assembled’ sheet based approach for cardiac tissue
engineering. In this approach, neonatal rat cardiomyocytes
were cultured on temperature-responsive culture dishes
[51–53]. After harvest, electrical coupling of layered
cardiomyocyte sheets occurred quickly through functional
gap junction formation [54], and subsequent implantation in
subcutaneous position demonstrated that pulsatile, layered
cardiomyocyte sheets survived and grew for a prolonged
period of time [55]. The versatility of this method has made it
a good candidate to create functional and transplantable tissue
sheets obtained from various cell types including epidermal
keratinocytes [56], kidney epithelial cells [57] and periodontal
ligaments [58, 59]. It has already been used in a clinical
trial involving corneal transplantation, which promoted the
recovery of weakened vision [60].
2.5. Need for functional vascularization
One of the most critical present problems in the field of tissue
engineering is to provide vascular supply to thick constructs
[61, 62], as molecular diffusion can assure the exchange of
nutrients and oxygen only within an approximately ∼100 μm
thick layer of viable tissue [63, 64]. The provision of vascular
conduits that have been engineered in vitro to pre-vascularize
tissues [65–68] is a remarkable but not sufficient advancement,
as the immediate connection to blood flow upon implantation
still remains a problem.
For one application, self-assembly of cells into sheets
provided an indirect solution to this problem [69] by
sequential implantation of multiple cardiac sheets. Because
the thickness of a single cardiac sheet (<80 μm) was
smaller than the diffusional penetration depth of oxygen, the
host vasculature was given time (1–3 days) to vascularize
each individual transplanted sheet before the next one was
added during the following surgery. This way, 1 mm thick
vascularized myocardium was obtained. While achieving the
goal of functional vascularization of thick tissue-engineered
constructs in vivo, this method is clearly not applicable to
patients due to the medical risk of multiple surgical procedures.
Another approach enabled the generation of fully viable,
thick and functional cardiac tissue constructs in vitro using
microchanneled scaffolds and bioreactor perfusion systems
[70, 71]. The functional assembly of engineered cardiac
muscle in vitro was enhanced by oxygen supply provided
by mechanisms resembling those in normal vascularized
tissues. To mimic the capillary network, cardiomyocytes and
fibroblasts isolated from neonatal rat hearts were cultured on
a highly porous elastomer with a parallel array of channels
that were perfused with culture medium. To mimic oxygen
supply by hemoglobin, culture medium was supplemented
with a perfluorocarbon (PFC) emulsion. The structural
and functional properties of the constructs were markedly
improved, in a manner correlated to the improved supply of
oxygen to the cells. It was postulated that the channel arrays
can also serve as precursors for the formation of the vascular
network.
However, the transition and integration of a tissue from
an in vitro to an in vivo setting still needs to be addressed.
From a surgical point of view, a tissue-engineered graft
would contain a hierarchical macro- to micro-vascular tree
ending with a connectable artery and vein so that perfusion
of the whole graft could be immediately restored upon
implantation. In order to fabricate such a construct, three
gradual components of the vascular tree have to be formed:
the capillary network (∼10–20 μm, by induction of sprouting,
co-culture or by cytokines), intermediate microvessels (50–
500 μm, by microfabrication) and the macrovasculature (up
to 2 mm, by tissue engineering). Capillary networks can
form in co-cultures of osteoblasts or cardiomyocytes with
endothelial cells, by natural cell assembly in either sheet [65,
72] or spheroid [73, 74] cell culture systems. Despite major
improvements allowing design of microvascular networks
in vitro using microfluidic technologies [75], pre-vascularized
tissues face the challenge of functional anastomosis to the
host vasculature. Recent clinical trials with engineered blood
vessels using scaffold-based [7] and sheet-based methods [76]
illustrate that engineering of the macro-vasculature, including
the connectable artery and vein for surgical anastomosis,
seems to be within reach. It is hoped that these vessels
will exhibit mechanical competence (e.g. burst pressure,
compliance, suturability) and antithrombogenic properties
[77, 78]. However, it remains unclear how can the
macrovasculature be connected to the capillary tree and
perfused with blood.
2.6. Self-assembly of vascular networks
Self-assembly approaches may have major impact on the
development of the intermediate vasculature, which is the
‘missing link’ for establishing a perfused vascular tree.
Sefton and colleagues have reported a method based on
the modular assembly of endothelialized microtissues to
form macrotissues [79]. In this approach, modular tissue-
engineered constructs were assembled from sub-millimeter-
sized cylindrical modules of collagen or gelatin seeded with
cells, and endothelialized at the surfaces [79, 80]. EC-
covered modules then randomly self-assembled into a modular
construct with interstitial spaces that enabled perfusion with
medium or whole blood. It remains to be seen how stable
is the self-assembled microvasculature for the long term and
how it can integrate components enabling direct anastomosis
to the host vasculature in vivo. In a similar fashion, several
groups, including ours, are currently working on the fusion of
endothelialized spheroids as means for creating microvessels
in vitro [81–83].
To develop tissue-engineered constructs of clinically
relevant size with a fully functional vasculature that can
eventually be anastomosed to the host vasculature in vivo,
we suggest a self-assembly approach shown in figure 2.
A network of macrovessels, including a connectable artery
and vein, would be build (by bioprinting, see below), and then
matured using a perfusion bioreactor to achieve mechanical
properties necessary for implantation. Parenchymal and
endothelial cells would be co-cultured to produce micro-
vascularized units (in the form of cylindrical or spherical
multicellular aggregates), sized to be below the diffusion
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Figure 2. Model for thick construct tissue engineering using a
self-assembly approach. (a) A macrovascular network (from a few
mm to less than 1 mm in diameter) is built using bioprinting, then
matured for several weeks in a perfusion bioreactor (b), in order to
achieve adequate mechanical properties needed for future
implantation in the host. (c) Micro-vascularized multicellular
cylindrical modules (200 μm) are obtained from coaggregation of
endothelial cells and the cell type of interest (ex: hepatocytes), and
their surface is endothelialized. (d) EC-covered modules are then
randomly assembled into a modular construct within each lumen of
the macrovascular network (only one shown explicitly), and form
interconnected channels (intermediate microvasculature:
50–500 μm) under medium perfusion. (e) The entire construct is
then surgically connected to the host vasculature in an
arterio-venous position.
limitation. After the surfaces are endothelialized, pre-
vascularized units would be packed into the lumen of the
matured macro-vessels and perfused to promote self-assembly
of intermediate microvessels and their connection to a capillary
network, to enable implantation by direct anastomosis to the
host vasculature.
Cellular self-assembly approaches represent an alternative
and offer a complement to scaffold-based tissue engineering.
They allow establishing high cell density, controlled
deposition of extracellular matrix and positional specificity of
cell patterning. Translation of cell and tissue self-assembly
approaches into the clinical field will necessarily depend
on our ability to understand the principles underlying such
approaches.
In what follows, we present examples of early
developmental self-assembly processes that will be utilized
for the ‘biofabrication-by-bioprinting’ technology.
3. Developmental mechanisms of cellular
self-assembly
It is through cellular self-assembly that the morphologically
featureless zygote evolves into the fully developed organism
with its numerous structures of widely varied shapes and
forms. Although the sequence of morphogenetic processes
that underlies early development is under strict genetic control,
additional physical mechanisms are mobilized to move mass
and make shapes. In turn, the changes brought about by
physical processes (e.g. diffusion, changes in shape, molecular
and ion concentrations) provide feedback to gene expression.
The interplay of genetic and physical processes is the hallmark
of embryonic development. A better understanding of this
interplay would enhance our ability to employ the principles of
cellular self-assembly in the biofabrication of living constructs.
In this section, we review characteristic morphogenetic
mechanisms that are utilized in the biofabrication technology
to be discussed in the next section.
3.1. Cell sorting
Cell sorting is a self-assembly process providing a common
mechanism to establish cellular compartments and boundaries
between distinct tissues [84–87]. To understand the molecular
basis of cell sorting, let us consider lumen or cavity
formation. As cells in an initially homogeneous cell
population differentiate, they may become polarized and
express cell adhesion molecules only on restricted parts of their
surface. As a consequence, if minimization of configurational
energy is the driving force in cell rearrangement, a lumen is
bound to appear (figure 3).
Lumen formation is a simple manifestation of the
differential adhesion hypothesis (DAH; [89, 90]), which
postulates that cells of different type adhere to each other
with different strengths (such as the polarized and non-
polarized cells in figure 3). The DAH may also provide a
simple molecular explanation for cell sorting: an initially
mixed population of differentially adhesive cells, either due
to quantitative ([90]; figure 4) or qualitative ([91, 92];
figure 5; see also figure 8) differences in cell surface adhesion
molecules, evolves to a compartmentalized state in which the
more adhesive cells aggregate and become surrounded by
the less adhesive ones. As sorting requires the cells to be
motile, this morphogenetic mechanism is most active during
embryonic development, where adhesive contacts (through
cell adhesion molecules such as cadherins or selectins) are
not yet at the mature stage as in an adult organism (e.g. tight
junctions, gap junctions) [88].
Figure 3. Schematics of lumen formation as a consequence of
differential adhesion. The shading in some cells in the middle panel
represents the lack of adhesion molecules on corresponding regions
of the cells. These cells sort through the mixture and orient
themselves to form a lumen or cavity [88]. (Figure reproduced with
permission of Cambridge University Press.)
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(a) (b)
Figure 4. Sorting in a mixture of cells based on differential adhesiveness. (a) Sorting of two genetically transformed Chinese Hamster
ovary (CHO) cell populations with ∼30% difference in N-cadherin expression (green cells contain more N-cadherins). Aggregates (200 μm
in diameter) contain equal number (∼6000) of the two cell types (i.e. green and red), and sort within ∼24 h. (b) Schematic illustration of
adhesion molecules (bars ending in circles) on the surfaces of the two CHO cell populations. To minimize the configurational energy, highly
adhesive cells tend to group together. (Figure reproduced with permission of Cambridge University Press from [88].)
Figure 5. The images show the full cross-section of a 200 μm diameter spheroidal aggregate consisting of a mixture of chicken embryonic
pigmented epithelial (dark) and neural retinal (light) cells. The three panels correspond to the times of 17, 42 and 73 h after the initiation of
sorting [96]. (Figure reproduced with permission of Proc. Natl Acad. Sci. USA.)
Figure 6. In vitro fusion of two embryonic cell aggregates. Snapshots of two apposed embryonic cushion tissue spheroids cultured in a
hanging drop configuration fuse into a single spheroid over a period of ∼1 day [42]. Scale bar: 100 μm.
Though interpretation of sorting by DAH is appealing
and elegant, recent developments suggest the situation may be
more complicated; compartment boundaries between tissues
may result from the synergistic effect of differential cell
adhesion and cellular tensile forces generated by acto-myosin-
dependent cell cortex tensions [91–95].
3.2. Tissue fusion
Tissue fusion is a self-assembly process in which two or
more distinct cell populations make contact and coalesce.
The fusion process underlies the formation of numerous
structures in the embryo (for specific examples see [86]).
Figure 6 illustrates the in vitro fusion of two multicellular
aggregates [42]. A striking in vivo example is shown in
figure 7 [81].
3.3. Apparent tissue liquidity
During sorting and fusion, the cellular system evolves in time
from an initial state to a structurally and energetically more
stable final state. It is an intriguing question what drives
the underlying equilibration processes. As sorting and fusion
strikingly resemble, respectively, the phase separation and
coalescence in liquids, it was proposed that adhesive and
motile cell populations have apparent liquid-like properties
[98–100]. Based on this analogy, cell sorting and tissue fusion
should be driven by apparent surface and interfacial tension.
An apparent tissue surface tension has been measured using
methods applicable to liquids [101–103] for a large variety
of naturally occurring tissues [102, 104–106] and tissue cell
aggregates [101, 103, 107–110].
It was suggested that the notion of apparent tissue surface
tension is intimately related to DAH [108]: differences in
6
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(a) (b) (c)
(d) (e) (f )
Figure 7. Formation of the descending aorta by fusion of the pair of dorsal aortae (81). Panels represent a series of cross-sections of the
posterior–anterior axis in an E9.5 mouse embryo, arranged in a posterior to anterior direction. (a)–(c) Asterisks indicate the lumens of the
paired dorsal aortae; arrow in (c) shows the cellular septum separating the two aortae. Insets in (b) and (c) show high-magnification views of
the interface region between fusing dorsal aortae. (d) Arrow shows a remnant of the cellular septum. Inset in (d) shows a high-magnification
view of the remnant of the cellular septum in the dorsal aorta. Scale bars: 50 μm. (Reproduced with permission of Wiley Interscience
Publishing Co.)
Figure 8. Correspondence between the sorted patterns and apparent
tissue surface tension. Data are shown for five chicken embryonic
tissues [88, 101]. (Figure reproduced with permission of Cambridge
University Press from [88].)
apparent tissue surface tension are quantitative measures of
differential cell adhesion. In particular, the measured values
of these tensions are consistent with the observed sorting
behavior: the tissue of higher surface tension is surrounded by
the one of lower surface tension as shown in figure 8, similar to
immiscible liquids, such as oil and water. Furthermore, using
engineered cell lines it was demonstrated that apparent tissue
surface tension is proportional to the number of cell surface
adhesion molecules [108], implying that the more cohesive the
tissue the higher its surface tension. The final sorted and fused
tissue configurations, respectively shown in figures 8 and 6
can then be understood as equilibrium states with the lowest
interfacial energy. As gravitational forces are negligible and
other external forces do not act, in these states the cellular
assemblies assume spherical shape.
The spontaneous rounding up of embryonic tissue
fragments (figure 9) and multicellular aggregates was one of
the first indications of the liquid-like nature of such cellular
assemblies. Cellular spheroids are extensively used as close-
to-physiological three-dimensional cell culture models that
can be easily and reproducibly fabricated using a variety of
rapid prototyping methods [45, 46, 111] (see section 4).
It is important to note that the concept of tissue liquidity
establishes analogy as opposed to identity between true liquids
and cellular assemblies: the motion of liquid molecules
is driven by thermal fluctuations with characteristic energy
kBT (kB is the Boltzmann constant and T is the absolute
temperature), whereas the motion of cells is driven by
metabolic energy resulting from ATP hydrolysis. Therefore,
it is even more striking that not only the final sorted and fused
configurations are liquid like, but so is the approach to these
final states. Indeed, the time sequence shown in figure 6 can
be described by the theory of highly viscous liquids [112–
115]. Tissue liquidity, albeit a useful and convenient concept,
is still not a universal morphogenetic principle. Processes
that are consistent with tissue liquidity may act at one stage
of early development but not at another. Indeed, apparent
surface tension is typically a meaningful quantity only for a
period of time that depends on tissue type [101]. Nevertheless,
it is exciting that cellular properties can be summarized
using just a few parameters (e.g. surface tension, viscosity,
elastic constants) to describe large-scale tissue behavior with
relevance to the fabrication of multicellular living constructs.
4. Engineering and fabricating tissues by
bioprinting
Recently, several research groups have embarked on
engineering three-dimensional living structures using
bioprinting. Two main distinct technologies have emerged.
One relies on the use of inkjet printing [116–124]. In this
7
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Figure 9. The spontaneous rounding of tissue fragments. The rounding of tissue fragments (∼300 μm in size) of 4 day embryonic chick leg,
wing and flank tissue that occurs within 24 h in vitro, is viewed as an indication of liquid-like behavior. The fragments were photographed
successively after explant, and at 5 h, 11.5 h, 17.5 h and 24 h thereafter [104]. (Figure reproduced with permission of Elsevier, Inc.)
technology, either individual cells or small clusters are printed.
The method is rapid, versatile and cheap. Its disadvantage is
that it is difficult to assure high cell density needed for the
fabrication of solid organ structures. Furthermore, due to the
high speed of cell deposition, considerable damage is caused to
cells, although the latest developments in the field have led to
considerable improvement in cell survival. Finally, to achieve
appropriate structural organization and functionality remain a
challenge.
In the other approach, mechanical extruders [125, 126]
are used to place ‘bio-ink’ particles, multicellular aggregates
of definite composition into a supporting environment,
the ‘bio-paper’, according to computer-generated templates
consistent with the topology of the desired biological structure
[42, 45, 97]. Organoids form by the postprinting fusion of
the bio-ink particles and the sorting of cells within the bio-ink
particles. The advantage of this technology is that the bio-ink
particles represent small three-dimensional tissue fragments.
Thus, cells in them are in a more physiologically relevant
arrangement, with adhesive contacts with their neighbors,
which may assure the transmission of vital molecular signals.
The method employs early developmental mechanisms, such
as tissue fusion and cell sorting. The disadvantage of the
method is associated with the relatively high cost of the
printers. Both inkjet and extruder bioprinting are compatible
with rapid prototyping.
In this section, we review the latest developments
in extruder-based bioprinting technology developed in our
laboratory (figure 10). In particular, we first describe how the
multicellular bio-ink particles are prepared and subsequently
discuss how the special-purpose extruder printers deliver them
according to computer-generated templates. For specificity
we will use the process of engineering vascular grafts.
4.1. Fabrication of self-assembling, multicellular building
blocks
Multicellular bio-ink building blocks are prepared from cell
suspensions. They can be homogeneous, containing a single
(a) (b) (c) (d )
Figure 10. Components of the print-based tissue-engineering
technology. (a) The bio-ink-filled micropipette printer cartridge
filled with multicellular building blocks that can be spheroidal (left)
or cylindrical (right) depending on the method of preparation.
(b) The bio-printer. Three-dimensional printing is achieved by
displacement of the three-axis positioning system (stage in y and
printing heads along x and z (top: Neatco, Carlisle, Canada; bottom:
Organovo-Invetech, San Diego)). (c) Spheroids are delivered one by
one into the hydrogel bio-paper (itself printed) according to a
computer script. (d) Layer-by-layer deposition of cylindrical units
of bio-paper (shown in blue) and multicellular cylindrical building
blocks. The outcome of printing (spheroids in panel (c),
multicellular cylinders in panel (d)) is a set of discrete units, which
postprinting fuse to form a continuous structure.
cell type or heterogeneous, made from a mixture of several
cell types. Bio-ink particles typically used in our laboratory
are either spherical or cylindrical in shape. Multiple methods
have been described to prepare spherical aggregates [45, 46,
111, 127].
Here we briefly describe one method for the preparation
of the spherical or cylindrical units (figure 11). The cell
suspension is centrifuged and the resulting pellet is transferred
into a capillary micropipette. After a short incubation in
medium at 37 ◦C, cell–cell interactions are restored and
the cylindrical slurry becomes sturdy enough to be extruded
into liquid. The spherical building blocks are obtained by
mechanically cutting uniform fragments that spontaneously
round up as a manifestation of tissue liquidity. If the slurry
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(a)
(b) (c)
Figure 11. Preparation of the multicellular building blocks.
(a) Preparation of spherical building blocks. The cell slurry
extruded from a micropipette is cut into cylindrical fragments (with
identical diameter and height) of equal size using a custom device.
Spherical bio-ink particles are formed by rounding of the cylinders
upon overnight incubation on a gyratory shaker. A scanning electron
microscopy picture of a 500 μm spheroid composed of endothelial
cells is shown. The spheroids are packaged into the bio-ink-filled
micropipette printer cartridge just before printing. (b) Preparation of
cylindrical building blocks. Up to ten multicellular slurries can be
simultaneously extruded into a non-adhesive agarose mold using a
customized attachment to the bioprinter. After overnight maturation,
the multicellular cylinders are strong enough to be printed.
is composed of multiple cell types, sorting and rounding
will occur in parallel. As for embryonic tissues, the sorting
behavior is driven by differences in tissue surface tension of
the cell aggregates (figure 12). The fabrication of cylindrical
building blocks requires maturation of the slurries in a
non-adhesive mold overnight to improve their cohesivity.
Automation of the deposition step into the mold has been
achieved and was important for the high quality of cellular
cylinders and the rate of their production.
4.2. Bio-ink deposition
The extrusion-based bioprinting described here represents an
automated deposition method that enables the building of 3D
custom-shaped tissue and organ modules without the use of any
scaffold. In this way, a fully biological construct is generated
that is structurally and functionally close to a native tissue.
Spherical or cylindrical multicellular units—the bio-ink—
are delivered according to a computer-generated template
together with hydrogel—the bio-paper—serving as support
material.
Different deposition schemes have been employed for 3D
tissue bioprinting as the technology evolved. The scheme
shown in figure 13 was used initially to establish proof
of concept. Despite some successful outcomes [42], the
rapidity, reproducibility and scalability of the technique were
challenged by a few shortcomings.
Figure 12. Time evolution of cell sorting in multicellular
aggregates. Aggregates composed of endothelial cells (yellow)
and fibroblasts (red) (left column) and endothelial cells (EC)
(yellow) and smooth muscle cells (SMC) (green) (right column)
are shown. The sorting pattern can be attributed to the differences in
the apparent surface tension of multicellular assemblies prepared
from the two cell types, similarly to the situation shown in
figure 8 (endothelial cell aggregates: 12 dyne cm−1; fibroblast
aggregates: 72.7 dyne cm−1, smooth muscle cell aggregates:
279 dyne cm−1).
One limitation of this early system was that the success
of printing depended strongly on the control of the gelation
state of the collagen-hydrogel layers. Uneven gelation
compromised the spatial accuracy of the construct in particular
for constructs thicker than a few layers [42]. In addition,
collagen was remodeled by the cells and integrated into the
final structure, such that its removal was challenging. Another
limitation arose during printing constructs of larger size and
more complex pattern (i.e. branching tubes). The preparation
of spheroids in large quantities (>1000 for branched tubular
structures) became excessively time consuming. Finally,
the manual filling of the micropipette printer cartridge
with the cellular spheroids (one by one) represented a
serious challenge (e.g. it had to be assured that no gaps
between the spheroids appeared upon their aspiration into the
micropipette).
To overcome the above limitations, we replaced the
collagen sheets with agarose rods (figure 14) and we used
cylindrical multicellular building blocks instead of spheroids
(figures 10 and 14). The agarose rods are formed in situ
and deposited by the bioprinter automatically, rapidly and
accurately. Agarose is an inert and biocompatible hydrogel
that cells neither invade nor rearrange. The agarose rods kept
their integrity during post-printing fusion, and were easily
removed to free the fused multicellular construct.
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(a) (b) (c) (d )
Figure 13. Layer–by-layer deposition. (a) A sheet of biocompatible hydrogel is printed, and the building blocks are embedded into the
hydrogel. (b) and (c) The alternate deposition of layers of hydrogel and building blocks is pursued according to the predefined blueprint of
the desired 3D structure (here, a tubular construct). (d) Fusion of the building blocks and removal of the hydrogel result in a hollow tube
after a few days.
(a) (b) (c) (d) (e) (f)
Figure 14. Horizontal layer-by-layer deposition of the building blocks. (a)–(e) A possible deposition scheme for a tubular structure built of
agarose rods and spherical multicellular building blocks. (f ) The same tubular configuration printed with cylindrical multicellular building
blocks.
4.3. Self-assembly of the building blocks
A living cell-based construct that results from the described
printing process and the postprinting fusion of the bio-
ink particles is subsequently placed in an incubator where
it achieves its final 3D structure and through maturation
develops appropriate biomechanical properties. Proof of
concept studies have been carried out to build tissue toroids,
thick sheets and straight and branched tubes ([42, 45];
figure 15).
It was demonstrated that no biological functionality was
lost in the bioprinting process when the sheet obtained
by the fusion of chick cardiac cell spheroids exhibited
synchronous macroscopic beating throughout the construct.
When endothelial cells were mixed with the cardiac cells, self-
assembly led to the formation of vessel-like conduits [42].
Our current efforts are focused on the bioprinting of
small and intermediate diameter blood vessel substitutes ([45],
figure 16(a)). As the print-based technology exploits the
intrinsic self-organizing properties of cells and tissues, it
incorporates some of the natural vessel forming processes.
During embryonic vasculogenesis and angiogenesis, the initial
steps are performed by the ECs as they form the elementary
tubular conduits. Under shear stress, the ECs secrete the
growth factors PDGF and TGFβ and the associated molecular
signals are responsible for the recruitment of SMCs and the
induction of ECM deposition (i.e. collagen and elastin). In
particular, TGFβ plays a key role in the production of elastin,
an ECM component that not only is responsible for the elastic
properties of the vessels but also regulates the sequestration
and activation of the growth factors [128].
Using the described print-based technology, tubular
structures can be built from mixtures of randomly distributed
ECs and SMCs, which offers a unique opportunity to exploit
the EC/SMC interaction from the initial step of vessel
formation. Endothelium is expected to form during the
postprinting fusion and sorting (figure 16(b)). Applying flow
to the forming endothelium in the early stage will stimulate
ECs to behave as they do in vivo. The anticipated benefits
will be the production of a more physiological ECM (both
in composition and organization), better attachment of the
endothelium and faster maturation. To mimic the blood vessel
structure, a double-layered vascular tube has been constructed
(figure 16(c)).
In conclusion, the novel print-based tissue-engineering
technology has several distinct features with great potential for
the generation of tissue and organ structures: (i) it represents an
approach for producing fully biological (scaffold-free) small
diameter vessels; (ii) it utilizes natural shape-forming (i.e.
morphogenetic) processes, that are present during normal
development; (iii) it can provide organoids of complex
topology (i.e. branching tubes) and (iv) it is scalable and
compatible with methods of rapid prototyping.
5. Future perspectives
While regenerative medicine is far from providing
‘replacement parts’ and tissue regeneration therapies ready to
be used in patients, we seem to be getting increasingly closer
to the development of treatment modalities for re-establishing
tissue structure and function. The rapid development of the
field is largely driven by the medical needs of our aging
population, and by recent developments in stem cell biology
and technologies of cell and tissue engineering. In the
last few years, tissue engineering went through some major
changes that might be indicative of the future trends in this
field.
Overall, a largely empirical approach to tissue engineering
(‘tissue try this’, as cleverly described by Shannon Dahl)
is being replaced by the development of developmentally
inspired technologies (approaches based on bioprinting and
self-assembly being remarkable examples). Consequently,
one major focus is on the cells. With the living cell being
the ultimate ‘tissue engineer’, our effort is being directed to
providing the conditions, so that the cells do the engineering.
Another focus is on technology. After major breakthroughs
in stem cell biology, we are now developing technologies
for ‘instructing’ the cells to regenerate defective tissues by
providing a highly engineered environment.
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(a) (b) (c) (d )
Figure 15. Printing of geometrically complex multicellular
constructs. (a) 500 μm bio-ink particles (top), composed of Chinese
Hamster ovary (CHO) cells were printed on 1.3 mg/ml collagen
bio-paper, in circle (aggregates are labeled alternatively with red and
green dyes). A fused toroid forms after ∼60 h (bottom) [42].
(b) Chick cardiac cell aggregates printed into sheet (top). A fused
sheet, after focus ∼70 h (bottom) [42]. (c) A branching conduit
printed using spherical units; bottom panel shows the fused
structure. (d) A 12-layered printed CHO tube using spherical units
(top). Cross-section of the fused tube made with units composed of
SMCs (green) and ECs (red) (bottom).
(a) (b) (c)
Figure 16. (a) Design templates (top) and fused constructs (bottom)
of different vessel diameters built with cylindrical bio-ink. (b) The
top image shows a template to build a construct with spheroids
composed of SMC (red) and ECs (green). A transversal section after
fusion (bottom) shows that the lumen is composed predominantly of
endothelial cells. (c) Template to construct a double-layered
vascular tube (top). The inner layer is constructed of SMC building
blocks (green), the outer of fibroblast building blocks (red). The
transversal section (bottom) shows fusion and the segregation of the
two cell types mimicking the media and adventitia of blood vessels.
These focus points are illustrations of the paradigm
shift in the field toward the establishment of a ‘biomimetic’
approach, that is based on the premise that unlocking the
full biological potential of stem cells (in vitro or in vivo)
necessitates an environment similar to that present during
native development. This paradigm is guiding many current
tissue-engineering approaches, including those based on cell
self-assembly that holds promise of building fully biological
tissues with structural and functional specification. We
described the potential of the self-assembly-based technology
for the formation of a hierarchically defined vascular tree
perfused with blood, one of the main unsolved problems in
tissue engineering. It is highly possible that in the future this
technology can also help build other complex tissues, such as
stratified and anisotropic structures consisting of multiple cell
types and tissue subunits. For this to happen, we will need
to continue to cross the boundaries between the disciplines,
and take advantage of the synergism of developmental and
adult biology, biomaterials science, biomedical engineering
and medicine.
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